LivaNova

Youtube Subscribe

Open: 57.35 Close: 57.14 Change: -0.21

The top 15 things about LivaNova found by an AI.

Are looking for the most relevant information about LivaNova? Investor spend a lot of time searching for information to make investment decisions in LivaNova. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about LivaNova are: LivaNova, PLC, Q2, post, Corp, FY23, CEO, and the most common words in the summary are: livanova, market, stock, anonymous, late, medical, plc, . One of the sentences in the summary was: Texas Permanent School Fund Corp owned about 0.09% of LivaNovas worth $2,092,000.. Other searches …

Concept Map

Semantic Network

Stock Summary

LivaNova PLC designs, develops, manufactures, and sells therapeutic solutions. The Cardiopulmonary segment develops, produces, and markets cardiopul pulmonary products. Neuromodulation segment designs, markets VNS Therapy.

Today's Summary

LivaNova PLC posted mixed Q2 FY23 results with growth observed in the P&L and balance sheet. CEO William Kozy is Interim Chief Executive Officer and Chair of the Board. Texas Permanent School Fund Corp owned about 0.09% of LivaNovas worth $2,092,000.

Today's News

LivaNova PLC beats Q2 top and bottom line estimates; raises FY23 outlook. CEO to step down, co sees preliminary Q1 revenue above consensus. CEO William Kozy is Interim Chief Executive Officer and Chair of the Board. LivaNova PLC posted mixed Q2 FY23 results, with growth observed in the P&L and balance sheet. Stifel Nicolaus Sticks to Their Buy Rating for Liva LivaNova PLC posted Q2 results last week with a mixed set of numbers. Ten-year agreement with Novartis demonstrates broad and deep commitment to accelerating disease and therapeutic-specific insights based on proprietary proteomic technology Boulder, Colo., USA. LivaNova PLC has a twelve month low of $40.26 and a twelve-month high of $66.73. Sell-side analysts expect that LivaNovas PLC will post 2.39 EPS for the current fiscal year. LivaNova PLC distinguishes itself as an innovative medical device manufacturer offering therapeutic solutions globally since its inception several years ago. With three main segments – Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support – LivaNovas boasts an impressive array of products designed to address diverse healthcare needs. Texas Permanent School Fund Corp owned about 0.09% of LivaNova worth $2,092,000. Bank of America Corp DE lifted its stake in Liva nova by 38.5% in the 4th quarter. Van ECK Associates Corp acquired a new stake in the fourth quarter worth approximately $430,000.

Stock Profile

"LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. It also engages in research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom."

Keywords

How much time have you spent trying to decide whether investing in LivaNova? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about LivaNova are: LivaNova, PLC, Q2, post, Corp, FY23, CEO, and the most common words in the summary are: livanova, market, stock, anonymous, late, medical, plc, . One of the sentences in the summary was: Texas Permanent School Fund Corp owned about 0.09% of LivaNovas worth $2,092,000.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #livanova #market #stock #anonymous #late #medical #plc.

Read more →

Youtube Subscribe

---